Table 3.

Adverse events occurred in >3% of patients during abiraterone treatment.

	Total number of patients with adverse events (N = 231)
	Mild	Moderate	Severe	Total
Asthenia	29 (12.6%)	4 (1.7%)	2 (0.9%)	35 (15.2%)
Edema	13 (5.6%)	5 (2.2%)		16 (6.9%)
Diarrhea	14 (6.1%)	1 (0.4%)		15 (6.5%)
Anemia	9 (3.9%)	3 (1.3%)	3 (1.3%)	14 (6.1%)
Fatigue	10 (4.3%)	3 (1.3%)	1 (0.4%)	14 (6.1%)
Fever	11 (4.8%)	2 (0.9%)	1 (0.4%)	14 (6.1%)
Dyspnea	9 (3.9%)	3 (1.3%)		12 (5.2%)
Nausea	9 (3.9%)	3 (1.3%)	1 (0.4%)	12 (5.2%)
Cough	10 (4.3%)	1 (0.4%)		11 (4.8%)
Constipation	8 (3.5%)	2 (0.9%)	1 (0.4%)	10 (4.3%)
Pain	9 (3.9%)	2 (0.9%)		10 (4.3%)
Death unexpected			8 (3.5%)	8 (3.5%)
Atrial fibrillation	2 (0.9%)	5 (2.2%)		7 (3.0%)
Hot flushes	6 (2.6%)	1 (0.4%)		7 (3.0%)
Pneumonitis	1 (0.4%)	4 (1.7%)	2 (0.9%)	7 (3.0%)
Back pain	5 (2.2%)	2 (0.9%)		7 (3.0%)
Urinary incontinence	7 (3.0%)			7 (3.0%)